27986757|t|Cyanate - Impaired Angiogenesis: Association With Poor Coronary Collateral Growth in Patients With Stable Angina and Chronic Total Occlusion
27986757|a|Cyanate has recently gained attention for its role in the pathogenesis of vascular injury. Nonetheless, the effect of cyanate on angiogenesis remains unclear. In this study, we demonstrated that oral administration of cyanate impaired blood perfusion recovery in a mouse hind-limb ischemia model. A reduction in blood perfusion recovery at day 21 was observed in the ischemic tissue of cyanate - treated mice. Likewise, there were fewer capillaries in the ischemic hind-limb tissue of cyanate - exposed mice. Our in vitro study showed that cyanate, together with its carbamylated products, inhibited the migration, proliferation, and tube-formation abilities of endothelial cells. Further research revealed that cyanate regulated angiogenesis partly by interrupting the vascular endothelial growth factor receptor 2 / phosphatidylinositol 3-kinase / Akt pathway. The serum concentrations of homocitrulline, a marker of cyanate exposure, were determined in 117 patients with stable angina and chronic total occlusion. Consistent with the antiangiogenic role of cyanate, homocitrulline levels were increased in patients with poor coronary collateralization (n=58) compared with those with high collateralization (n=59; 21.09±13.08 versus 15.54±9.02 ng/mL, P=0.009). In addition, elevated homocitrulline concentration was a strong predictor of poor coronary collateral growth. Impaired angiogenesis induced by cyanate might contribute to poor coronary collateral growth.
27986757	0	7	Cyanate	T103	UMLS:C0302938
27986757	19	31	Angiogenesis	T038	UMLS:C0302600
27986757	55	81	Coronary Collateral Growth	T038	UMLS:C1820269
27986757	99	112	Stable Angina	T038	UMLS:C0340288
27986757	117	140	Chronic Total Occlusion	T038	UMLS:C1955779
27986757	141	148	Cyanate	T103	UMLS:C0302938
27986757	199	211	pathogenesis	T038	UMLS:C0699748
27986757	215	230	vascular injury	T037	UMLS:C0178324
27986757	259	266	cyanate	T103	UMLS:C0302938
27986757	270	282	angiogenesis	T038	UMLS:C0302600
27986757	308	313	study	T062	UMLS:C2603343
27986757	336	355	oral administration	T058	UMLS:C0001563
27986757	359	366	cyanate	T103	UMLS:C0302938
27986757	406	436	mouse hind-limb ischemia model	T038	UMLS:C2986594
27986757	440	449	reduction	T058	UMLS:C0441610
27986757	517	523	tissue	T017	UMLS:C0040300
27986757	527	534	cyanate	T103	UMLS:C0302938
27986757	545	549	mice	T204	UMLS:C0025929
27986757	578	589	capillaries	T017	UMLS:C0006901
27986757	606	615	hind-limb	T017	UMLS:C1522391
27986757	616	622	tissue	T017	UMLS:C0040300
27986757	626	633	cyanate	T103	UMLS:C0302938
27986757	644	648	mice	T204	UMLS:C0025929
27986757	663	668	study	T062	UMLS:C2603343
27986757	681	688	cyanate	T103	UMLS:C0302938
27986757	745	754	migration	T038	UMLS:C1622501
27986757	756	769	proliferation	T038	UMLS:C0596290
27986757	775	789	tube-formation	T038	UMLS:C2752214
27986757	803	820	endothelial cells	T017	UMLS:C0225336
27986757	830	838	research	T062	UMLS:C0035168
27986757	853	860	cyanate	T103	UMLS:C0302938
27986757	871	883	angiogenesis	T038	UMLS:C0302600
27986757	911	956	vascular endothelial growth factor receptor 2	T103	UMLS:C0378796
27986757	959	988	phosphatidylinositol 3-kinase	T103	UMLS:C0044602
27986757	991	1002	Akt pathway	T038	UMLS:C1515844
27986757	1032	1046	homocitrulline	T103	UMLS:C0062931
27986757	1050	1056	marker	T201	UMLS:C0005516
27986757	1060	1067	cyanate	T103	UMLS:C0302938
27986757	1115	1128	stable angina	T038	UMLS:C0340288
27986757	1133	1156	chronic total occlusion	T038	UMLS:C1955779
27986757	1178	1197	antiangiogenic role	T038	UMLS:C3179230
27986757	1201	1208	cyanate	T103	UMLS:C0302938
27986757	1210	1231	homocitrulline levels	T058	UMLS:C0523699
27986757	1269	1295	coronary collateralization	T038	UMLS:C1820269
27986757	1333	1350	collateralization	T082	UMLS:C1948058
27986757	1427	1441	homocitrulline	T103	UMLS:C0062931
27986757	1487	1513	coronary collateral growth	T038	UMLS:C1820269
27986757	1524	1536	angiogenesis	T038	UMLS:C0302600
27986757	1548	1555	cyanate	T103	UMLS:C0302938
27986757	1581	1607	coronary collateral growth	T038	UMLS:C1820269